Avantax Advisory Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

Avantax Advisory Services’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-19,147	Closed	-$397K	–	2361
2025 Q1	$397K	Sell	19,147 -9,554	-33%	-$240K	﹤0.01%	1660
2024 Q4	$676K	Buy	28,701 +702	+3%	+$17.3K	﹤0.01%	1260
2024 Q3	$717K	Buy	27,999 +12,600	+82%	+$321K	﹤0.01%	1196
2024 Q2	$362K	Buy	+15,399	New	+$389K	﹤0.01%	1576
2023 Q3	–	Sell	-6,959	Closed	-$237K	–	1550
2023 Q2	$237K	Sell	6,959 -362	-5%	-$11.4K	﹤0.01%	1313
2023 Q1	$220K	Sell	7,321 -1,271	-15%	-$39.4K	﹤0.01%	1316
2022 Q4	$243K	Sell	8,592 -734	-8%	-$23.3K	﹤0.01%	1219
2022 Q3	$307K	Sell	9,326 -1,557	-14%	-$57.2K	﹤0.01%	994
2022 Q2	$343K	Buy	10,883 +231	+2%	+$8.08K	0.01%	947
2022 Q1	$493K	Buy	10,652 +38	+0.4%	+$1.81K	0.01%	795
2021 Q4	$650K	Sell	10,614 -4,238	-29%	-$293K	0.01%	669
2021 Q3	$1.11M	Sell	14,852 -581	-4%	-$48.7K	0.02%	460
2021 Q2	$1.43M	Sell	15,433 -1,501	-9%	-$128K	0.03%	400
2021 Q1	$1.5M	Buy	16,934 +4,624	+38%	+$459K	0.03%	351
2020 Q4	$1.15M	Sell	12,310 -13,828	-53%	-$1.1M	0.03%	369
2020 Q3	$1.67M	Buy	26,138 +19,248	+279%	+$1.13M	0.03%	401
2020 Q2	$360K	Buy	+6,890	New	+$296K	0.01%	578

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Avantax Advisory Services's ARKG Position: Q2 2025 in Review

Avantax Advisory Services sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2025, closing a stake of 19,147 shares — an estimated $397K sold.

Avantax Advisory Services first reported a position in ARKG in Q2 2020 and held it in 17 quarters. The position peaked at $1.67M in Q3 2020. 213 funds tracked by Wall St. Rank hold ARKG as of Q2 2025.

Avantax Advisory Services reported no remaining ARK Genomic Revolution ETF position as of Q2 2025 after selling out during the quarter.
Avantax Advisory Services sold 19,147 ARK Genomic Revolution ETF shares in Q2 2025, an estimated $397K.
Avantax Advisory Services first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 17 quarters.
Avantax Advisory Services's ARK Genomic Revolution ETF position peaked at $1.67M in Q3 2020.
213 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2025.

Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.